Amphion Innovations PLC Fundamentals Datasheet and Stock Analysis
Amphion Innovations plc is engaged in creating, building, operating and financing life science and technology companies (the Partner Companies) in partnership with corporations, governments, universities and entrepreneurs seeking to commercialize their intellectual property (IP). The Company also maintains an active IP licensing program. It operates through three segments: advisory services, investing activities and intellectual property. Its operations are located in the United States and the United Kingdom. It provides a range of services, including direct management, strategic planning, intellectual property planning and strategy, capital raising, recruiting, business development, and other services in areas, such as marketing, administration and capital markets. These services allow it to have direct knowledge of the operations of the Partner Companies, and allow the Company to identify and seek remedies for financial and operational issues occurring at the Partner Companies.
- Current Price:0.43p
- Industry:Financials
- Sector:Financial Services
- ISIN:GB00B0DJNP99
- Market Sector:AIM
- Main Indices:FTSE AIM
- Country of register:Great Britain
- Currency:N/A
- Shares in Issue:210m
- Market Cap:£1m
- Date Listed:20/03/2007
Loading...
Activity Data Not Available
CEO: Richard Cecil Eversfield Morgan CFO: Robert Joseph Bertoldi Non-Executive Director: Paul Kennedy, Philip Tansey, Anthony William Henfrey, Stephen Austin Gerard Moufflet
- Registrars:
- Address:330 Madison Avenue, New York, United States of America
- Phone:(212) 210 6282
- Website:http://www.amphionplc.com
Composite Ranking: 25Historic EPS Ranking: 8Forecast EPS Ranking: 1Price Relative Strength: Industry Strength: ASMR Ranking: ROCE Ranking: DAccumulation/Dist: CMkt Accumulation/Dist: CUnbroken Annual EPS: EUnbroken Interim EPS: EPEG Current Ranking: APEG Forecast Ranking: APE Current Ranking: APE Forecast Ranking: AMargin Current Ranking: HMargin Forecast Ranking: D
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018E | 2019E | 2020E | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Day/Month | 31/12 | 31/12 | 31/12 | 31/12 | 31/12 | 31/12 | 31/12 | 31/12 | 31/12 | ||
| Revenue | $m | 1.40 | 1.02 | 0.48 | 0.52 | 0.14 | 0.29 | $m | 0.00 | 0.00 | 0.00 |
| Operating Profit/(loss) | $m | (6.43) | (2.58) | (3.01) | (4.16) | (3.33) | (2.86) | $m | 0.00 | 0.00 | 0.00 |
| Profit Before Tax | $m | (6.94) | (6.39) | (12.59) | 5.94 | (16.84) | 2.50 | $m | 0.00 | 0.00 | 0.00 |
| Profit After Tax | $m | (6.95) | (6.38) | (12.59) | 5.94 | (16.84) | 2.50 | $m | 0.00 | 0.00 | 0.00 |
| Profit After Tax (from discontinued operations) | $m | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | $m | 0.00 | 0.00 | 0.00 |
| Overall Profit for the Period | $m | (6.95) | (6.38) | (12.59) | 5.94 | (16.84) | 2.50 | $m | 0.00 | 0.00 | 0.00 |
| EPS Growth | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | % | (100.00) | (100.00) | 0.00 |
| Earnings Per Share | ¢ | (4.00) | (4.00) | (9.00) | 2.00 | (9.00) | 1.00 | p | 0.00 | 0.00 | 0.00 |
| Op. Cash Flow P/S | ¢ | (0.02) | (0.01) | (0.02) | (0.02) | (0.01) | (0.01) | $ | 0.00 | 0.00 | 0.00 |
| Cash Flow P/S Grth | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | % | 0.00 | 0.00 | 0.00 |
| Net Cash Flow P/S | ¢ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | $ | 0.00 | 0.00 | 0.00 |
| Capital Exp P/S | $ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | $ | 0.00 | 0.00 | 0.00 |
| Tax Rate | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | % | 0.00 | 0.00 | 0.00 |
| P/E Ratio | x | 0.00 | 0.00 | 0.00 | 1.50 | 0.00 | 2.30 | x | 0.00 | 0.00 | 0.00 |
| P/E Growth | $ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | $ | 0.00 | 0.00 | 0.00 |
| Turnover Per Share | $ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | $ | 0.00 | 0.00 | 0.00 |
| Pre-Tax Profit / Share | $ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | $ | 0.00 | 0.00 | 0.00 |
| Operating Margin | % | (460.95) | (253.37) | (627.08) | (800.00) | (2,378.57) | (986.21) | % | 0.00 | 0.00 | 0.00 |
| ROCE | % | (28.84) | (35.00) | (444.40) | 65.47 | 261.54 | (139.84) | % | 0.00 | 0.00 | 0.00 |
| ROE | % | (29.46) | (36.83) | (160.75) | 95.24 | (672.96) | 0.00 | % | 0.00 | 0.00 | 0.00 |
| Mkt Cap | $m | 7.09 | 8.92 | 2.36 | 7.09 | 5.25 | 3.67 | $m | 0.00 | 0.00 | 0.00 |
| Dividend Per Share | ¢ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | p | 0.00 | 0.00 | 0.00 |
| DPS Growth | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | % | 0.00 | 0.00 | 0.00 |
| Dividend Yield | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | % | 0.00 | 0.00 | 0.00 |
| Dividend Cover | x | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | x | 0.00 | 0.00 | 0.00 |
| Shareholder Funds | $m | 20.58 | 14.08 | 1.59 | 10.89 | (5.89) | (2.81) | $m | 0.00 | 0.00 | 0.00 |
| Net Borrowings | $m | (0.41) | (0.35) | (0.21) | (0.94) | (0.31) | (1.04) | $m | 0.00 | 0.00 | 0.00 |
| Net Assets | $m | 20.58 | 14.08 | 1.59 | 10.89 | (5.89) | (2.81) | $m | 0.00 | 0.00 | 0.00 |
| Net Assets P/S | $ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | $ | 0.00 | 0.00 | 0.00 |
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | 0.0% | 0.0% |
| Op Margin | -986.2% | 0.0% |
| ROCE | 20.3% |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 15-Dec-16 | Personal Equity Plan - buy | Miroslaw Izienicki | 2.12p | 281,250 | £5,962.50 |
| 07-Jan-16 | Buy | Miroslaw Izienicki | 3.38p | 198,056 | £6,684.39 |
| 07-Jan-16 | Buy | Gerard Moufflet | 3.38p | 93,750 | £3,164.06 |
| 16-Sep-15 | Buy | Richard James Macaleer | 0.06p | 285,000 | £17,812.50 |
| 16-Sep-15 | Buy | Miroslaw Izienicki | 0.06p | 220,100 | £13,756.25 |
| 16-Sep-15 | Buy | Gerard Moufflet | 0.06p | 93,750 | £5,859.38 |
| 24-Sep-14 | Buy | Richard James Macaleer | 2.23p | 518,356 | £11,533.42 |
| 24-Sep-14 | Buy | Richard James Macaleer | 2.23p | 518,356 | £11,533 |
| 24-Sep-14 | Buy | Miroslaw Izienicki | 2.23p | 102,083 | £2,271.35 |
| 24-Sep-14 | Buy | Gerard Moufflet | 2.23p | 83,333 | £1,854.16 |
| Notifier | Holding | Value |
|---|---|---|
| Richard Cecil Eversfield Morgan | 23,642,499 | e,662.75 |
| Robert Joseph Bertoldi | 6,436,431 | ,676.65 |
| Gerard Moufflet | 1,320,833 | ,679.58 |
| Anthony William Henfrey | 1,190,735 | ,120.16 |
| News Title | Date | Time | Source |
|---|---|---|---|
| Sale of Partner Company Shares | 19-Mar-19 | 14:33 | RNS |
| Price Monitoring Extension | 18-Mar-19 | 14:00 | RNS |
| Sale of Partner Company Shares | 15-Mar-19 | 07:00 | RNS |
| Amended Terms on Loan Facility | 11-Mar-19 | 16:41 | RNS |
| Convertible Promissory Note Extended | 26-Feb-19 | 07:00 | RNS |
| Statement re. Motif Bio plc | 14-Feb-19 | 08:00 | RNS |
| Stmnt re Share Price Movement | 07-Feb-19 | 09:40 | RNS |
| Appointment of Joint Broker | 01-Feb-19 | 07:00 | RNS |
| WellGen Finalises License Agreement | 21-Jan-19 | 07:00 | RNS |
| Investment in Polarean & Loan Facility Repayment | 11-Dec-18 | 07:05 | RNS |